Why nutraceuticals do not prevent or treat Alzheimer's disease

Nutrition Journal

Volumn 4, Issue , 2005, Pages

  Fisher, Anna E O ^a   Naughton, Declan P ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CLIOQUINOL; COPPER; METAL CHELATE; NUTRACEUTICAL; SUPEROXIDE DISMUTASE; ZINC;

ALZHEIMER DISEASE; CLINICAL RESEARCH; DIET THERAPY; ENZYME ACTIVITY; HUMAN; LONG TERM CARE; NEUROTOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; CHELATING AGENTS; COPPER; HUMANS; IRON; METALS; NEUROFIBRILLARY TANGLES; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXIDATIVE STRESS; PLAQUE, AMYLOID; VITAMINS;

EID: 18944367125     PISSN: 14752891     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-4-14     Document Type: Review

References (29)

1. Luchsinger JA, Mayeux R: Dietary factors and Alzheimer's disease. Lancet Neurol 2004, 3:579-587.
2. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI: Characterization of copper interactions with Alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β1-42. J Neurochem 2000, 75:1219-1233.
3. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI: Dramatic Aggregation of Alzheimer Abeta by Cu(II) Is Induced by Conditions Representing Physiological Acidosis. J Biol Chem 1998, 273:12817-12826.
4. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR: Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998, 158:47-52.
5. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM: Elevation of serum copper levels in Alzheimer's disease. Neurology 2002, 59:1153-1161.
6. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, et al.: Cu(II) potentiation of alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999, 274:37111-37116.
7. 2. J Biol Chem 2002, 277:40302-40308.
8. Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling KQ, Huang X, Moir RD, Wang D, Sayre LM, et al.: Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 2004, 43:560-568.
9. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ, Masters CL, Bush AI, Barnham KJ: Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 2001, 276:20466-20473.
10. Dobson J: Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001, 496:1-5.
11. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA: RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999, 19:1959-1964.
12. Schipper HM: Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 2004, 37:1995-2011.
13. Perry G, Nunomura A, Hirai K, Zhu X, Prez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM: Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 2002, 33:1475-1479.
14. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P, et al.: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003, 24:915-919.
15. Kontush A, Mann U, Arlt S, Ujeyl A, Luhrs C, Muller-Thomsen T, Beisiegel U: Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med 2001, 31:345-354.
16. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, Breteler MMB: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287:3223-3229.
17. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA: Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Assoc 2002, 287:3230-3237.
18. Luchsinger JA, Tang MX, Shea S, Mayeux R: Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003, 60:203-208.
19. White AR, Barnham KJ, Huang X, Voltakis I, Beyreuther K, Masters CL, Cherny RA, Bush AI, Cappai R: Iron inhibits neurotoxicity induced by trace copper and biological reductants. J Biol Inorg Chem 2004, 9:269-280.
20. Bush AI: Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging 2002, 23:1031-1038.
21. Doraiswamy PM, Finefrock AE: Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 2004, 3:431-434.
22. Cherny RA, Barnham KJ, Lynch T, Volitakis I, Li QX, McLean CA, Multhaup G, Beyreuther K, Tanzi RE, Masters CL, Bush AI: Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. J Struct Biol 2000, 130:209-216.
23. Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li X, Moir RD, Tanzi RE, Bush AI: Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis. Exp Gerontol 2004, 39:1641-1649.
24. Zheng H, Weiner LM, Bar-Am O, Epsztejn S, Cabantchik ZI, Warshawsky A, Youdim MBH, Fridkin M: Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg Med Chem 2004 in press.
25. Lee JY, Friedman JE, Angel I, Kozak A, Koh JY: The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging 2004, 25:1315-1321.
26. Fisher AEO, Naughton DP: Novel peptoids for the detection and suppression of reactive oxygen and nitrogen species. Biochem Soc Trans 2003, 31:1302-1304.
27. Fisher AEO, Maxwell SC, Naughton DP: Catalase and superoxide dismutase mimics for the treatment of inflammatory diseases. Inorg Chem Comm 2003, 6:1205-1208.
28. Maskos Z, Rush JD, Koppenol WH: The hydroxylation of tryptophan. Arch Biochem Biophys 1992, 296:514-520.
29. Fisher AEO, Hague TA, Clarke CL, Naughton DP: Catalytic superoxide scavenging by metal complexes of the calcium chelator EGTA and contrast agent EHPG. Biochem Biophys Res Comm 2004, 323:163-167.